Shanxi Zhendong Pharmaceutical Cash Flow-to-Debt Ratio
Shanxi Zhendong Pharmaceutical cash flow-to-debt ratio. Shanxi Zhendong Pharmaceutical (300158) has a Cash Flow-to-Debt Ratio of -0.22x as of September 2025, meaning its operating cash flow of CN¥-197.94 Million could theoretically repay 0% of its total liabilities (CN¥882.65 Million) in one year. Check Shanxi Zhendong Pharmaceutical (300158) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Shanxi Zhendong Pharmaceutical (2007–2024)
Cash flow-to-debt ratio of Shanxi Zhendong Pharmaceutical from 2007 to 2024. Historical debt coverage capacity for Shanxi Zhendong Pharmaceutical across 18 annual periods. Check 300158 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Shanxi Zhendong Pharmaceutical Cash Flow-to-Debt Ratio by Year (2007–2024)
Shanxi Zhendong Pharmaceutical cash flow-to-debt ratio by year from 2007 to 2024. Year-by-year debt coverage analysis for Shanxi Zhendong Pharmaceutical. For the full cash flow conversion analysis, see cash efficiency ratio of Shanxi Zhendong Pharmaceutical.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -0.11x | CN¥-149.82 Million | CN¥1.32 Billion | ▲ +38.2% |
| 2023 | -0.18x | CN¥-189.95 Million | CN¥1.04 Billion | ▼ -381.9% |
| 2022 | 0.07x | CN¥86.31 Million | CN¥1.33 Billion | ▼ -53.4% |
| 2021 | 0.14x | CN¥284.45 Million | CN¥2.04 Billion | ▲ +23.8% |
| 2020 | 0.11x | CN¥221.94 Million | CN¥1.97 Billion | ▼ -10.9% |
| 2019 | 0.13x | CN¥186.35 Million | CN¥1.47 Billion | ▲ +51.4% |
| 2018 | 0.08x | CN¥154.48 Million | CN¥1.85 Billion | ▲ +280.7% |
| 2017 | 0.02x | CN¥45.09 Million | CN¥2.06 Billion | ▲ +178.6% |
| 2016 | -0.03x | CN¥-44.72 Million | CN¥1.60 Billion | ▼ -137.5% |
| 2015 | 0.07x | CN¥151.84 Million | CN¥2.04 Billion | ▼ -9.7% |
| 2014 | 0.08x | CN¥73.23 Million | CN¥888.23 Million | ▲ +192.1% |
| 2013 | -0.09x | CN¥-75.04 Million | CN¥838.64 Million | ▼ -132.3% |
| 2012 | 0.28x | CN¥189.40 Million | CN¥684.26 Million | ▲ +224.0% |
| 2011 | -0.22x | CN¥-88.73 Million | CN¥397.40 Million | ▼ -368.2% |
| 2010 | 0.08x | CN¥32.40 Million | CN¥389.13 Million | ▼ -44.1% |
| 2009 | 0.15x | CN¥42.28 Million | CN¥283.87 Million | ▲ +3.2% |
| 2008 | 0.14x | CN¥33.18 Million | CN¥229.98 Million | ▼ -67.4% |
| 2007 | 0.44x | CN¥128.65 Million | CN¥290.28 Million | — |